Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
MA09 - EGFR & MET
- 15:15 - 16:45
- 9/08/2019
- Location: Melbourne (1991)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Jordi Remon, Juergen Wolf
-
+
MA09.09 - Long-Term Outcomes to Tepotinib Plus Gefitinib in Patients with EGFR-Mutant NSCLC and MET Dysregulation: 18‑Month Follow-Up
16:15 - 16:20 | Presenter: Yi-Long Wu | Author(s): Ying Cheng, Jianying Zhou, Shun Lu, Yiping Zhang, Jun Zhao, Dong-Wan Kim, Ross Soo, Sang-we Kim, Hongming Pan, Yuh-Min Chen, Chih-Feng Chian, Xiaoqing Liu, Daniel SW Tan, Rolf Bruns, Josef Straub, Andreas Johne, Jürgen Scheele, Keunchil Park, James Chih-Hsin Yang
- Abstract
Loading...
-
+
MA11 - Immunotherapy in Special Populations and Predictive Markers
- 14:00 - 15:30
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Immuno-oncology
- Moderators:Frank Griesinger, Lecia Sequist
-
+
MA11.06 - A PII Study of Toripalimab, a PD-1 mAb, in Combination with Chemotherapy in EGFR+ Advanced NSCLC Patients Failed to Prior EGFR TKI Therapies
14:35 - 14:40 | Presenter: Jie Zhang | Author(s): Caicun Zhou, yanqiu Zhao, Xiaoqian Mu, Jianying Zhou, Zhang Bao, Yun Fan, Yanjun Xu, Yongqian Yong Shu, Renhua Guo, Xiaoqing Liu, Hong Wang, Helong Zhang, Lin Deng, Ningqiang Ma, Jianxing He, Yalei Zhang, mo Chen, Yinrui Jiang
- Abstract
Loading...
-
+
MA14 - The Adequate MTarget Is Still the Issue
- 15:45 - 17:15
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Diego Signorelli, Juergen Wolf
-
+
MA14.05 - A Randomized Phase III Trial of Fruquintinib Versus Placebo in Patients with Advanced Non-Small Cell Lung Cancer (FALUCA)
16:15 - 16:20 | Presenter: Shun Lu | Author(s): Gongyan Chen, yuping Sun, sanyuan Sun, Jianhua Chang, yu Yao, Zhendong Chen, feng Ye, Junguo Lu, Jianhua Shi, Jianxing He, xiaoqing Liu, Yiping Zhang, zhihua Liu, Jian Fang, Ying Cheng, chunhong Hu, weidong Mao, Yanping Hu, Youling Gong, Li Shan, zhixiong Yang, Yong Song, wei Li, chong Bai, buhai Wang, rui Ma, zhendong Zheng, mingfang Liu, zhijun Jie, Lejie Cao, wangjun Liao, Hongming Pan, dongning Huang, Yuan Chen, jinji Yang, shukui Qin, Shenglin Ma, Li Liang, zhe Liu, Jianying Zhou, Min Tao, yijiang Huang, feng Qiu, yunchao Huang, Ye Hua, yiping Chen, weiguo Su
- Abstract
Loading...
-
+
MA15 - Usage of Computer and Molecular Analysis in Treatment Selection and Disease Prognostication
- 15:45 - 17:15
- 9/09/2019
- Location: Tokyo (1982)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Pathology
- Moderators:John Le Quesne, Noriko Motoi
-
+
MA15.02 - Deep Learning Approach for Automated Tumor Cells Detection and Estimation of PD-L1 22C3 Assay Expression in Lung Adenocarcinoma
15:50 - 15:55 | Presenter: Jianghua Wu | Author(s): Dongmei Lin, Wei Sun, Changling Liu, Xiaoqing Liu, Yajun Zhang, Junjie Zhang, Haiyue Wang, Xinying Liu, Xin Yang, Shaoping Ling
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-99 - A Phase IIIb Open-Label Study of Afatinib in EGFR TKI-Naïve Patients with EGFR Mutation-Positive NSCLC: Final Analysis
10:15 - 10:15 | Presenter: Yi-Long Wu | Author(s): Haiyan Tu, Jifeng Feng, Meiqi Shi, Jun Zhao, Yuyan Wang, Jianhua Chang, Jialei Wang, Ying Cheng, Jing Zhu, Eng-Huat Tan, Yiping Zhang, Victor Lee, Cheng-Ta Yang, Wu-Chou Su, David Chi-Leung Lam, BJ Srinivasa, Senthil Rajappa, Ching-Liang Ho, Kwok Chi Lam, Yi Hu, Shailesh Arjun Bondarde, Xiaoqing Liu, Kaimin Pang, Yahui Tian, Agnieszka Cseh, Dennis Chin-Lun Huang, Caicun Zhou
- Abstract
Loading...